Sort
17,288 grants matching “multiple sclerosis”
CD24 as Therapeutic Target for Multiple Sclerosis-phase II Competing Renewal
$493,610Dexing Fang · Oncoimmune, Inc. · R44 · FY2010 · NS
Sex differences in brain inflammation in experimental stroke
$493,572Halina Offner · Oregon Health & Science University · R01 · FY2012 · NS
Spinocerebellar Ataxia Type 2 Gene and Gene Product
$493,335Stefan M. Pulst · University Of Utah · R37 · FY2016 · NS
Spinocerebellar Ataxia Type 2 Gene and Gene Product
$493,335Stefan M. Pulst · University Of Utah · R37 · FY2017 · NS
Spinocerebellar Ataxia Type 2 Gene and Gene Product
$493,335Stefan M. Pulst · University Of Utah · R37 · FY2015 · NS
HYBRID-FES EXERCISE TO PREVENT CARDIOPULMONARY DECLINES IN ACUTE HIGH LEVEL SCI
$493,266J Andrew Taylor · Spaulding Rehabilitation Hospital · R01 · FY2021 · HL
HYBRID-FES EXERCISE TO PREVENT CARDIOPULMONARY DECLINES IN ACUTE HIGH LEVEL SCI
$493,266J Andrew Taylor · Spaulding Rehabilitation Hospital · R01 · FY2022 · HL
HYBRID-FES EXERCISE TO PREVENT CARDIOPULMONARY DECLINES IN ACUTE HIGH LEVEL SCI
$493,266J Andrew Taylor · Spaulding Rehabilitation Hospital · R01 · FY2023 · HL
Intermediates in Protein Folding
$493,179Carl Frieden · Washington University · R01 · FY2006 · DK
Exploring the modulation of synaptic/extrasynaptic NMDAR balance as a novel therapeutic strategy in Alzheimer's disease and other neurodegenerations
$492,744Antonio Sanz-Clemente · Northwestern University At Chicago · R01 · FY2020 · AG
Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.
$492,372Michael Marcel Lederman · Case Western Reserve University · R33 · FY2016 · AI
Disease relevance of CD20 expression on T cells in multiple sclerosis patients
$492,230Stephen L Hauser · University Of California, San Francisco · R01 · FY2017 · NS
Studies of HLA Region Genomics in Systemic Sclerosis and Ankylosing Spondyilitis
$492,173Xiaodong Zhou · University Of Texas Hlth Sci Ctr Houston · U01 · FY2013 · AI
Preclinical models, biomarkers, and therapy for myotonic dystrophy type 1
$492,139Maurice S Swanson · University Of Rochester · P50 · FY2021 · NS
Viruses and Autoimmunity
$491,937J. Lindsay Whitton · La Jolla Institute For Immunology · P01 · FY2008 · AI
Exploring the modulation of synaptic/extrasynaptic NMDAR balance as a novel therapeutic strategy in Alzheimer's disease and other neurodegenerations
$491,840Antonio Sanz-Clemente · Northwestern University At Chicago · R01 · FY2021 · AG
Nitroxides as Protectors Against Oxidative Stress
$491,802James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Neonatal Stroke: The Role of Microglia-derived Extracellular Vesicles
$491,614Zinaida Vexler · University Of California, San Francisco · R01 · FY2021 · NS
Neonatal Stroke: The Role of Microglia-derived Extracellular Vesicles
$491,614Zinaida Vexler · University Of California, San Francisco · R01 · FY2020 · NS
Building Health Empowerment Zones for People with Disabilities
$491,523James Rimmer · University Of Illinois At Chicago · R01 · FY2008 · HD
Medicinal chemistry campaign to synthesize synaptamide analogs (GPR110)
$491,448Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Cerebral Artery Integrity Linked to Brain Injury and Cognition in Congenital Heart Disease
$491,416Nancy Ann Pike · University Of California Los Angeles · R01 · FY2019 · NR
Neuroglial interactions at nodes of Ranvier
$491,402Matthew N Rasband · Baylor College Of Medicine · R01 · FY2020 · NS
Neuroglial interactions at nodes of Ranvier
$491,402Matthew N Rasband · Baylor College Of Medicine · R01 · FY2019 · NS
Multi-Center Validation of Biomarkers for Motor Neuron Disease
$491,399Robert P Bowser · University Of Pittsburgh At Pittsburgh · RC1 · FY2009 · NS